Related Experiment Videos
Immune selection in murine tumors. Ph.d thesis.
Inge Marie Svane1, Anne-Marie Engel
1Institute for Medical Microbiology and Immunology, University of Copenhagen, Denmark.
APMIS. Supplementum
|May 13, 2003
Summary
Tumor cells evade immune detection by downregulating MHC class I, hindering T-cell recognition. This study investigated immune selection in tumors, finding that T-cell deficient mice developed tumors with altered antigen presentation, impacting immune evasion strategies.
Area of Science:
- Immunology
- Oncology
- Molecular Biology
Background:
- Tumor cells express unique antigens, theoretically targeted by T-cell immune surveillance.
- MHC class I molecules are crucial for presenting intracellular antigens to T cells.
- Reduced MHC class I expression is linked to tumor immune evasion and increased cancer incidence.
Purpose of the Study:
- To confirm T-cell-mediated immune selection in primary tumors.
- To assess if low MHC class I expression impairs antigen presentation in tumors.
- To identify molecular mechanisms underlying antigen processing and presentation defects in tumors.
Main Methods:
- Induced tumors in immunologically normal and T-cell defective mice using 3-methylcholanthrene.
- Transplanted tumor cell lines to assess immunogenicity and MHC class I expression.
- Investigated antigen-presenting capacity using viral infection and cytotoxic T-cell assays.
- Analyzed proteasome composition, heat shock proteins, TAP function, and interferon-gamma response.
Main Results:
- Tumors in T-cell defective mice showed shorter induction times and higher frequency, suggesting T-cell inhibition in normal mice.
- Transplanted tumors from normal mice were largely accepted (non-immunogenic), while those from T-cell defective mice were rejected (immunogenic).
- MHC class I expression varied widely and did not correlate with immunogenicity; some tumors from normal mice had higher expression.
- Deviant MHC class I mRNA transcription without surface protein changes occurred in tumors from immunodeficient mice.
- Antigen presentation ability correlated with MHC class I expression, but defects in proteasomes, heat shock proteins, or TAP were not evident.
- Most tumors responded to interferon-gamma, but three cell lines showed defective signaling due to impaired Stat1 phosphorylation.
Conclusions:
- T-cell mediated immune selection influences tumor development and immunogenicity.
- Tumor cells can evade immune detection through mechanisms beyond simple MHC class I downregulation.
- Defective interferon-gamma signaling in a subset of tumors represents a novel immune evasion pathway.